Abstract: A back plate configured to support a circuit board includes a body. The body defines a central recess formed into a top surface thereof, and a raised main support column extending from the central recess and adapted to support the circuit board.

Abstract: An electronic apparatus includes a main circuit board, an electronic device, side circuit boards, and a pressure applying unit. The electronic device is installed on and electrically connected to the main circuit board. The side circuit boards are positioned at edges of the electronic device on a side of the electronic device away from the main circuit board and electrically connected to the electronic device. The pressure applying unit is positioned on a side of the electronic device and on each of the side circuit boards away from the main circuit board. The pressure applying unit applies pressure: 1) to the side circuit boards to maintain an electrical connection between the side circuit boards and the electronic device; and 2) to side regions of the electronic device to maintain an electrical connection between the main circuit board and the electronic device.

Abstract: Provided herein are methods of synthesizing quinazoline compounds comprising at least one atropisomeric center.

Abstract: Techniques are provided for data replication using reinforcement learning to dynamically initiate the transfer of replication data. One method comprises obtaining a state for transferring replication data from a first storage system to a second storage system, wherein the state comprises an amount of replication data to be transferred to the second storage system; assigning a reward value to previously completed replication sessions based on whether a respective previously completed replication session satisfies a designated data recovery objective; determining a start time, using a reinforcement learning framework, for transferring the replication data to the second storage system, wherein the determining is based on the assigned reward values; and initiating the transfer of the replication data to the second storage system using the determined start time.

Abstract: Provided herein are methods to synthesize compounds useful in the treatment of cancer where such compounds comprise a quinazolinyl core moiety and at least one stereoisomeric or atropisomeric moiety.

Abstract: A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.

Abstract: A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.

Abstract: A nanocrystalline magnetic conductive sheet for wireless charging and a preparation method therefor are provided. The nanocrystalline magnetic conductive sheet includes a composition of Fe(100-x-y-z-?-?-?)MxCuyM?zSi?B?X?, saturation magnetic induction is greater than or equal to 1.25T. The preparation method includes preparing an alloy with a preset composition of into an alloy strip with an initial state of amorphousness by a single roll rapid quenching method, annealing an amorphous alloy strip according to a preset annealing process, to obtain a nanocrystalline strip, performing a magnetic fragmentation process on the nanocrystalline strip, to obtain the nanocrystalline magnetic conductive sheet for wireless charging.

Abstract: A lock device for locking the sliding door comprises a first lock portion and a transmission portion. The transmission portion may move along relative to the first lock portion a predetermined path, so that the transmission portion may bring the sliding door to move along the predetermined path to open or close the sliding door. The transmission portion has a plurality of successively arranged mating portions for locking with the first lock portion. The first lock portion has a first position in which the first lock portion is locked with the transmission portion and a second position in which the first lock portion is released from the transmission portion. The transmission portion may be locked in different positions along the predetermined path by matching the first lock portion 110 with different mating portions, so that the sliding door can be locked in different positions.

Abstract: The invention disclosed herein relates to aza-quinoline compounds of Formula (I), pharmaceutical compositions comprising such compounds, and the use of such compounds for treating a disease or condition mediated by Enhancer of Zeste Homolog 2 (EZH2), Polycomb Repressive Complex 2 (PRC2), or a combination thereof.

Abstract: A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.

Abstract: A nanocrystalline magnetic conductive sheet for wireless charging and a preparation method therefor are provided. The nanocrystalline magnetic conductive sheet includes a composition of Fe(100-x-y-z-?-?-?)MxCuyM?zSi?B?X?, saturation magnetic induction is greater than or equal to 1.25 T. The preparation method includes preparing an alloy with a preset composition of into an alloy strip with an initial state of amorphousness by a single roll rapid quenching method, annealing an amorphous alloy strip according to a preset annealing process, to obtain a nanocrystalline strip, performing a magnetic fragmentation process on the nanocrystalline strip, to obtain the nanocrystalline magnetic conductive sheet for wireless charging.

Abstract: Provided aza-quinoline compounds of Formula (I), pharmaceutical compositions comprising such compounds; and the use of such compounds for treating a disease or condition mediate by Enhancer of Zeste Homolog 2 (EZH2), Polycomb Repressive Complex 2 (PRC2), or a combination thereof.

Abstract: A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.

Abstract: The present disclosure relates to the technical field of lock, especially to the lock device for locking the sliding door. The lock device comprises a first lock portion and a transmission portion. The transmission portion may move along relative to the first lock portion a predetermined path, so that the transmission portion may bring the sliding door to move along the predetermined path to open or close the sliding door. The transmission portion has a plurality of successively arranged mating portions for locking with the first lock portion. The first lock portion has a first position in which the first lock portion is locked with the transmission portion and a second position in which the first lock portion is released from the transmission portion. The transmission portion may be locked in different positions along the predetermined path by matching the first lock portion (110) with different mating portions, so that the sliding door can be locked in different positions.

Abstract: A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.

Abstract: A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.

Abstract: A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.

Abstract: Contemplated gas-liquid separators and especially subsea gas-liquid separators have a main pipe with a plurality of descending branch pipes that are fluidly coupled to the main pipe and each other such as to allow disengagement of the gas into the main pipe while liquid and sand descend into the lower ends of the branch pipes. Sand accumulation in the lower ends of the branch pipes is preferably prevented by lateral serial flow of liquid and sand from one branch pipe to the next and use of a flush liquid that is drawn from one or more branch pipes.

Abstract: A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.